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Abstract
The ability of the shark antimicrobial aminosterol squalamine to induce the leakage of polar fluorescent dyes from large
 .unilamellar phospholipid vesicles LUVs has been measured. Micromolar squalamine causes leakage of carboxyfluorescein
 .  .  .CF from vesicles prepared from the anionic phospholipids phosphatidylglycerol PG , phosphatidylserine PS , and
cardiolipin. Binding analyses based on the leakage data show that squalamine has its highest affinity to phosphatidylglycerol
membranes, followed by phosphatidylserine and cardiolipin membranes. Squalamine will also induce the leakage of CF
 .from phosphatidylcholine PC LUVs at low phospholipid concentrations. At high phospholipid concentrations, the leakage
of CF from PC LUVs deviates from a simple dose–response relationship, and it appears that some of the squalamine can no
longer cause leakage. Fluorescent dye leakage generated by squalamine is graded, suggesting the formation of a discrete
membrane pore rather than a generalized disruption of vesicular membranes. By using fluorescently labeled dextrans of
different molecular weight, material with molecular weight F4000 grmol is released from vesicles by squalamine, but
material with molecular weight G10,000 is retained. Negative stain electron microscopy of squalamine-treated LUVs
shows that squalamine decreases the average vesicular size in a concentration-dependent manner. Squalamine decreases the
size of vesicles containing anionic phospholipid at a lower squalaminerlipid molar ratio than pure PC LUVs. In a
centrifugation assay, squalamine solubilizes phospholipid, but only at significantly higher squalaminerphospholipid ratios
than required for either dye leakage or vesicle size reduction. Squalamine solubilizes PC at lower squalaminerphospholipid
ratios than PG. We suggest that squalamine complexes with phospholipid to form a discrete structure within the bilayers of
LUVs, resulting in the transient leakage of small encapsulated molecules. At higher squalaminerphospholipid ratios, these
structures release from the bilayers and aggregate to form either new vesicles or squalaminerphospholipid mixed micelles.
q 1998 Elsevier Science B.V.
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1. Introduction
The increasing incidence of antibiotic-resistant
bacteria and public awareness of chronic infection
has intensified efforts to discover novel antimicrobial
agents. A variety of higher organisms have been
found to synthesize and secrete antimicrobial sub-
stances which supplement the cellular and humoral
immune systems. Many of the antimicrobial agents
have been identified as peptides: defensins from
mammals, magainins from frogs, tachyplesins from
w xthe horseshoe crab, and cecropins from insects 1,2 .
These peptides all have fewer than 50 amino acids, of
which a high proportion are the basic amino acids
lysine and arginine. In the presence of a membrane
containing acidic lipids, or in a membrane mimetic
environment, many of the peptides have the ability to
form amphipathic a-helices. The number of basic
amino acids and the propensity of the peptide to form
an amphipathic helix influences the antimicrobial
w xactivity and selectivity of these agents 3 .
The novel antimicrobial agent squalamine 3b-N-
 w  .x 41- N- 3- 4-aminobutyl -1,3-diaminopropane -7a ,
 . .24j-dihydroxy-5-cholestane 24 R -sulfate was re-
w xcently isolated from the dogfish shark 4 . The struc-
ture of this water-soluble cationic steroid is shown in
Fig. 1. Squalamine exhibits antimicrobial activity
against a broad spectrum of microorganisms includ-
ing Escherichia, Staphylococcus, Streptococcus,
Candida, and Paramecium. The synthesis of
squalamine from 5-cholenic acid has been completed
w xin 17 steps 5 , and the synthetic squalamine has
identical activity to the natural aminosterol from
shark.
Due to its broad antimicrobial specificity,
squalamine is a promising therapeutic agent in the
treatment of microbial infections resistant to conven-
tional antibiotics. Squalamine contains a polyamine
Fig. 1. The structure of the antimicrobial aminosterol squalamine.
moiety which will be protonated at neutral pH. The
positive charges could bind to negatively charged
phospholipids on the surface of bacterial cells. An-
timicrobial peptides such as magainins have been
shown to preferentially bind to anionic phospholipids
w x6–8 , and are believed to lyse bacterial cells by
forming a transient pore through their plasma mem-
w xbrane 9,10 .
Many studies directed towards understanding the
mechanism of peptide antibiotics have been facili-
tated by the relative ease of preparing synthetic pep-
tides in high purity and yield. The mechanism by
which squalamine kills bacterial cells has not been
studied until now, in part because only limited quanti-
ties of isolated squalamine have been available. Our
laboratory has begun a systematic physico–chemical
approach to understanding squalamine’s mechanism
of action.
In this report, squalamine has been added to large
 .unilamellar vesicles LUVs , prepared from one of
several different phospholipids and loaded with the
self-quenching fluorescent dye carboxyfluorescein
 .CF . Squalamine is shown to promote the release of
CF from LUVs comprised of anionic phospholipids.
Squalamine also promotes leakage of CF from vesi-
cles comprised of the zwitterionic lipid phosphatidyl-
choline, but only at a much higher squalaminerlipid
molar ratio, and only at low vesicle concentrations.
By using vesicles with encapsulated 8-aminonaptha-
 .lene-1,3,6 trisulfonic acid ANTS and p-xylene-bis-
 .pyridinium bromide DPX , dye leakage was deter-
mined to follow a graded mechanism, as opposed to
an all-or-none mechanism. The size of the
squalamine-induced membrane defect was measured
using fluorescent-labeled dextrans. Also, the surfac-
tant-like nature of squalamine was tested using a
variety of biochemical and microscopic experiments.
From these results, a model describing the interaction
of squalamine with phospholipid bilayers is proposed.
2. Materials and methods
2.1. Chemicals
 .Egg yolk phosphatidylcholine PC , phosphatidyl-
 .glycerol derived from egg yolk PG , beef heart
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 .  .cardiolipin CL , and brain phosphatidylserine PS
were purchased from Avanti Polar Lipids Alabaster,
.  .AL . Carboxyfluorescein CF was purchased from
 .Fluka Ronkonkoma, NY , and purified by Sephadex
w xLH -20 colum n chrom atography 11 . 8-
 .Aminonapthalene-1,3,6 trisulfonic acid ANTS , p-
 .xylene-bis-pyridinium bromide DPX , and tetram-
 .ethylrhodamine-labeled dextran MWs10 kD were
 .purchased from Molecular Probes Eugene, OR . Or-
ange OT and 1-phenyl-N-napthalamine were pur-
 .chased from Aldrich Milwaukee, WI . The fluores-
 .cein-labeled dextrans FD-4 MWs4 kD and FD-70
 .MWs70 kD , as well as Sephacryl S-400-HR,
 .were purchased from Sigma St. Louis, MO . All
other chemicals were reagent grade and used without
further purification.
Squalamine was isolated from the liver of the
w xshark Squalus acanthias as previously described 4 ,
and purified as the trifluoroacetate salt. As deter-
mined by elemental analysis, the salt contains two
trifluoroacetate groups, resulting in an effective
molecular weight for squalamine of 923.5 grmol.
Aqueous stock squalamine solutions used for leakage
measurements were prepared at a concentration of 1
 .mgrml 1.08 mM . Stock solutions were stored at
48C.
2.2. Vesicle preparation
 .Large unilamellar vesicles LUVs with encapsu-
w xlated CF were prepared by extrusion 12 , using a
 .hand-held apparatus Avestin, Ottawa, Canada . Ap-
proximately 12 mg of lipid in chloroform solution
was dried under nitrogen gas, and then under vacuum
for at least 2 h. The dried lipid was resuspended into
buffer containing CF 20 mM Pipes, 10 mM NaCl, 1
.mM EDTA, 100 mM CF, pH 7.0 and vigorously
vortexed. The lipid suspension was freeze–thawed 10
cycles by alternately placing the sample in a dry
ice–acetone bath and a water bath thermostatically
regulated at 308C. The lipid suspension was then
extruded through one or two 100 nm polycarbonate
filters for 29 passes. Extravesicular CF was separated
from the loaded vesicles by passage through a 1=15
cm BioGel P6DG size exclusion chromatography
column, eluting with assay buffer 20 mM Pipes, 150
mM NaCl, 1 mM EDTA, pH 7.0; assay buffer is
osmotically balanced to the CF buffer encapsulated
w x.within the vesicles 6 . The vesicles were harvested
 .and stored at room temperature 20–228C for leak-
age studies, which were performed on the same day
as vesicle preparation. The phospholipid concentra-
tion of the vesicular solutions were measured by total
w xphosphate assay 13 .
 .To measure the mechanism of leakage see later ,
LUVs were prepared encapsulated with both the fluo-
rophore 8-aminonapthalene-1,3,6 trisulfonic acid
 .ANTS and the quenching agent p-xylene-bis-pyri-
 .dinium bromide DPX . Lipid was extruded in the
same manner as for CF loaded vesicles, except that
ANTSrDPX buffer 10 mM Pipes, 10 mM NaCl, 1
.mM EDTA, 50 mM ANTS, 50 mM DPX, pH 7.0
was used. Unencapsulated dyes were separated from
vesicles using a 1=18 cm Sephadex G-75 size ex-
clusion column. In our hands, size exclusion chro-
matography using P6DG best separates unencapsu-
lated CF from LUVs, while Sephadex G-75 best
separates free calcein or ANTSrDPX from LUVs.
Harvested vesicles were stored at 48C until use. No
loss of encapsulated fluorophore is observed within a
week of vesicle preparation.
2.3. Leakage measurements
The leakage of CF from LUVs was measured
using an Aminco Bowman spectrofluorimeter main-
tained at 308C, with l s490 nm and l s520ex em
 .nm. An aliquot of LUVs typically 10–100 ml was
added to assay buffer in a quartz fluorescence cuvette
and allowed to equilibrate to 308C for 5 min. A small
 .aliquot 2–20 ml of squalamine from an aqueous
stock solution of 1 mgrml was added to the cuvette,
and the solution vigorously stirred. The total solution
volume in the cuvette was 3.0 ml. Fluorescence
readings were recorded every 15 s for 2 min. After 2
min, 30 ml of a 10% Triton X-100 solution was
added to lyse all vesicles, and the fluorescence
recorded. Some experiments were performed with a
Photon Technologies, Quantamaster spectrofluori-
meter using the same experimental conditions. With
this instrument, sample fluorescence is recorded con-
tinuously.
Carboxyfluorescein leakage from LUVs induced
by squalamine addition was recorded as the percent
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leakage at 1 min, using the relationship
F yF .ts1 min 0% Leakage at 1 mins )100%
F yF .‘ 0
1 .
where F is the background fluorescence intensity0
before squalamine addition, F is the fluorescence‘
intensity after adding Triton X-100 to a final concen-
tration of 0.1%, and F is the fluorescencets1 min
intensity at 1 min after squalamine addition. Leakage
is expressed as the percentage of encapsulated dye
released.
Some of the acquired leakage data was used to
indirectly calculate a binding isotherm, employing a
w xmethod previously described in detail 6,14,15 . First,
the fractional leakage is measured as a function of
squalamine concentration at several fixed concentra-
tions of lipid. Next, a set of lines parallel to the
abscissa is drawn through the dose–response curves,
w xgiving for each line a set of pairs of squalamine ,init
w xlipid values that produce an equivalent fractional
w x w xleakage. Squalamine and lipid are the total mo-init
lar concentrations of squalamine and lipid, respec-
tively, and are functionally related to the concentra-
tions of free and bound squalamine by the conserva-
tion of mass equation
S s S qr L 2 .0 f
w x w xwhere S is the total squalamine concentration, S0 f
is the concentration of free squalamine, and r is the
molar concentration of bound squalamine per lipid.
w x w xSince all pairs of S , L values that produce a0
given fractional leakage must also produce the same
w x w xvalue of r, plots of S vs. L at constant fractional0
leakages are linear, with slopes of r and intercepts of
w x w xS . The set of r, S values obtained from thesef f
plots constitutes the binding isotherm, where the
slope of a line drawn through the experimental points
yields the isotherm in units of reciprocal concentra-
tion. For this study, only data acquired using low
 .phospholipid concentrations F5 mM can be used
to calculate binding isotherms; at high lipid concen-
trations, the concentration of free squalamine is too
low to provide a valid measurement.
2.4. Mode of dye leakage induced by squalamine
To distinguish between ‘all-or-none’ leakage vs.
‘graded’ leakage, the amount of self-quenching ex-
hibited by LUVs after squalamine treatment was
measured. The details of the method have been de-
w xscribed in detail elsewhere 9,16 . In brief, vesicles
were prepared either from PG, PS, or PC encapsulat-
 .ing a fluorophore 50 mM ANTS and a quenching
 .agent 50 mM DPX . First, DPX is incrementally
added to untreated vesicles disrupted with Triton
X-100, and a normalized fluorescence F rF sDPX max
Q was measured as a function of the DPX concen-out
tration. Next, squalamine was added to a new popula-
tion of vesicles, and the fluorescence increase moni-
tored until a stable fluorescence value was reached.
The vesicle solution was then titrated with quenching
agent 90 mM DPX, 10 mM Pipes, 1 mM EDTA, pH
.  .7.0 , and the total fluorescence F was measuredtotal
as a function of the DPX concentration. After the
final addition of DPX, Triton X-100 was added to
determine F . The quantity Q was defined to bemax total
equal to F rF . The result is the acquisition oftotal max
Q and Q for each concentration of DPX, whichtotal out
 .can be used to calculate the internal quenching Qins
and the fraction of ANTS released by squalamine
 .f through the equationout
Q sQ P f qQ P 1y f . 3 .  .total out out ins out
From this data, curves relating the internal quench-
ing of the vesicles relative to the external fluores-
cence are generated. If the internal quenching Q isins
independent of the extent of dye release, the leakage
mechanism is ‘all-or-none’. If Q varies with dyeins
release, the leakage mechanism is ‘graded’.
2.5. Sizing the squalamine-generated membrane pore
through the leakage of fluorescent dextrans
Membrane pores induced in bilayers by the addi-
tion of squalamine were sized using the methodology
w xdeveloped by Ladokhin et al. 17 . Vesicles contain-
 .ing the fluorescein labeled dextrans FD-4 2 mgrml
 .and FD-70 4 mgrml , and tetramethylrhodamine-
labeled dextran 3 mgrml, MWs10,000; abbrevi-
.ated TMR-10 were prepared by extrusion. Vesicles
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were separated from extravesicular fluorescent dye
by column chromatography, using a 38=1 cm
Sephacryl S-400-HR chromatography column eluting
with 10 mM HEPES, 50 mM KCl, 1 mM EDTA, 3
mM sodium azide, pH 7.0, at room temperature
 .20–228C , with a flow rate of 1.2 ml per minute.
 .Column fractions 0.75 ml were collected. The har-
vested LUVs were treated with either squalamine 0.5
.ml of 1.0 mgrml squalamine in distilled water or an
equal volume of distilled water as a control, and
incubated for 10 min. The vesiclersqualamine mix-
ture was placed on a second Sephacryl S-400-HR
column, and vesicles separated from dye which leaked
from the vesicles due to the addition of squalamine.
Column fractions were analyzed for fluorescence and
phospholipid. The vesicles were harvested,
lyophilized, resuspended in 1.0 ml of 0.1% Triton
X-100, chromatographed using a Sephacryl S-400-HR
column, and analyzed by fluorescence spectroscopy.
2.6. Electron microscopy
Large unilamellar vesicles were prepared as de-
scribed previously, using PC or a mixture of PCrPG
 .  .70%r30% wrw . Vesicle solution 50 ml was
added into a test tube, into which was added either 10
ml of distilled water or 10 ml of squalamine solution.
The tubes were incubated at room temperature for 2
min, and then sampled for electron microscopy.
Grids were prepared by suspending formvar in
0.25% ethylene dichloride for about 2 min, and then
putting the formvar on a glass slide. The plastic
formvar was floated on distilled water for 10 min.
Copper grids 500 mesh, Electron Microscopy Scien-
.tific, Washington, DC were placed on the formvar
film. Finally, the copper grids were dried overnight
by vacuum evaporation for carbon coating. The coated
grids were used immediately.
Negative staining of the liposome samples was
performed by placing a small drop of vesicular sam-
ple on the freshly prepared, dried surface for 8 min
and drawing off the excess liquid from the side with
 .filter paper. A drop of 2% wrv ammonium molyb-
 .date prefiltered through a 100 nm membrane at pH
8.0 was placed on the grids and allowed to stain for
30 s. Excess stain was removed, the grids were
air-dried and viewed with a Hitachi H-600 electron
microscope operated at 75 kV. The normal magnifi-
cation was corrected by calibration of the microscope
using a carbon grating replica 2160 crossed
.linesrmm; E.F. Fullam, Schenectady, NY . All sam-
ples were examined under the electron microscope
within 4 h of preparation. Vesicle diameters were
measured from electron micrographs taken at a mag-
nification of 20,000–40,000.
2.7. Critical micelle concentration measurements
 .The critical micelle concentration cmc of
squalamine was measured by two different dye parti-
tioning assays. In one assay, solutions of squalamine
in distilled water were prepared ranging in concentra-
tion between 3 mM and 2.3 mM. To 3 ml of each
solution was added 10 ml of 1-phenyl-N-naphthyla-
 .mine 10 mM in 95% ethanol , and the solutions
incubated at 308C for either 30 min or 24 h to
achieve equilibrium. The fluorescence of 1-phenyl-
N-naphthylamine was measured at 308C in an Am-
inco–Bowman spectrofluorimeter, using l s336ex
w xnm and l s462 nm 18 . For the second assay, 1em
ml of squalamine solution was added to 5 mg of
Orange OT. The samples were incubated with agita-
tion for 18 h at 308C, and then the absorbance of the
solubilized dye was measured at 492 nm using a
w xSpectronic 21 spectrophotometer 19 .
2.8. Squalamine-induced solubilization of phospho-
lipid multilamellar ˝esicles
 .Multilamellar vesicles MLVs were prepared from
both PG and PC by vigorous vortexing of dried lipid
into buffer 10 mM HEPES, 150 mM NaCl, 1 mM
.EDTA, pH 7.0 . Approximately 550 nmoles of phos-
pholipid were transferred into polycarbonate cen-
trifuge tubes, and diluted with 1.8 ml of the same
buffer. Squalamine solutions of varying concentration
are added to give a final volume of 3.0 ml, and
vigorously vortexed. After 10 min, the tubes are
centrifuged using a Beckman L8 Ultracentrifuge in a
 .70.1 Ti rotor at 50,000 rpm 171,000=g for 90
min. After centrifugation, the supernatant was sam-
pled for phospholipid using a total phosphate assay
w x13 .
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3. Results
3.1. Lysis of carboxyfluorescein-loaded large unil-
amellar ˝esicles
The ability of squalamine to induce the leakage of
the fluorescent dye carboxyfluorescein from LUVs
has been evaluated by measuring the time course of
 .leakage of CF from PG LUVs Fig. 2 . The leakage
kinetics appear to be biphasic, with a rapid initial
leakage of CF followed by a much slower phase.
Similar kinetics have been observed using vesicles
comprised of the anionic lipids PS and CL data not
.shown .
The leakage of dye from the vesicles was defined
as the percentage of the total encapsulated CF re-
leased from the LUVs 1 min after the addition of
squalamine. The total fluorescence trapped in the
vesicles was determined by lysing the vesicles with
Triton X-100. The leakage at 1 min was measured for
each concentration of lipid and squalamine tested.
The leakage was then plotted vs. the squalamine
concentration for several different PG concentrations,
and the data shown in Fig. 3. The data shown in Fig.
3 are typical results describing the leakage of CF
from anionic LUVs by squalamine; similar data was
acquired using the anionic phospholipids PS and CL.
3.2. Lipid specificity of squalamine
The relative affinity of squalamine for anionic
lipids was determined by leakage measurements us-
Fig. 2. The kinetics of carboxyfluorescein leakage from PG LUVs. Squalamine was added to PG LUVs phospholipid concentrations4.9
.mM to the final concentration indicated on the Figure, and the increase in CF fluorescence recorded. The fluorescence units are recorded
in counts per second.
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Fig. 3. A plot of leakage rate vs. squalamine concentration for
three different concentrations of PG LUVs. The leakage rate was
defined as the percentage of the total encapsulated CF released 1
min after the addition of squalamine.
ing LUVs prepared from the anionic lipids PG, PS,
and CL. Carboxyfluorescein leakage induced by
squalamine was determined as described above, and
this leakage was plotted against the logarithm of the
squalaminerphospholipid molar ratio for the differ-
 .ent phospholipid concentrations tested Fig. 4 . At
high lipid concentrations, the curves in Fig. 4 super-
impose, demonstrating that under these conditions the
measured leakage depends only upon the
squalaminerlipid ratio. This suggests that at high
phospholipid concentrations, the squalamine binds
tightly to the anionic lipid headgroups, resulting in a
very small concentration of unbound squalamine in
bulk solution. At low lipid concentrations, the curves
describing the relationship betw een the
squalaminerlipid ratio and the leakage separate, indi-
cating the presence of a steady-state concentration of
free squalamine in solution.
By using the data presented in Fig. 4, the relative
binding affinity of squalamine for the different phos-
pholipid headgroups can be assessed in two ways.
First, from the data acquired at high phospholipid
concentrations, the molar ratio of squalamine to phos-
pholipid required to induce 50% contents leakage in
1 min can be estimated. This ratio will be reported as
its base 10 logarithm and referred to as an ED value50
 .for effective dose . The more negative the ED , the50
Fig. 4. Dose–response curves describing the rate of leakage of
CF from anionic lipid LUVs as a function of the logarithm of the
squalaminerlipid molar ratio. At low lipid concentrations, the
dose–response curves separate; at higher concentrations, the leak-
age rate is solely dependent upon the squalaminerlipid molar
 .  .ratio. A Phosphatidylserine LUVs; B Phosphatidylglycerol
 .LUVs; C Cardiolipin LUVs. The solution phospholipid concen-
trations for each curve are listed for each study. The errors in the
w x w xleakage rate and the squalamine r phospholipid molar ratios are
estimated to be "5%.
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Table 1
Binding parameters describing the interaction of squalamine with
LUVs prepared from a single phospholipid species
y1 .Phospholipid K M EDb apparent 50
6PG 1.6=10 y0.95
5PS 9.4=10 y0.85
5CL 3.6=10 y0.30
4PC 6.5=10 ND
The K is calculated from leakage data acquired at lipidb apparent
phosphate concentrations F5 mM, as described in the text.
The error in the K calculated in this manner is estimatedb apparent
w xto be "20% 7 .
w x w x4The ED is the log squalamine r phospholipid representing50
the midpoint of the sigmoidal curves shown in Fig. 4 for saturat-
ing lipid concentrations, where the curves superimpose.
No value for ED could be determined for PC vesicles due to50
 .the lack of superimposable dose–response curves see Fig. 5 .
greater the affinity of squalamine for that particular
lipid. Second, leakage data can be used to calculate a
binding isotherm describing the association of
squalamine with phospholipid, as described in Sec-
w xtion 2.3 6,14,15 . The binding isotherms are calcu-
lated from leakage curves generated at phospholipid
concentrations of less than 5 mM, where the curves
do not superimpose and where the concentration of
free squalamine is significant relative to the concen-
tration of lipid-bound squalamine.
Both the ED values and the apparent binding50
 .constants K describing the binding ofb apparent
squalamine to phospholipids are reported in Table 1.
Squalamine binds approximately equally well to PS
and PG vesicles, with apparent binding constants of
approximately 106 My1. Squalamine binds somewhat
 5 y1.less well to CL vesicles K s3.6=10 M .b apparent
However, as CL contains two phosphate groups per
phospholipid, the affinity of squalamine per lipid
phosphate is not much less for CL than for PG or PS.
For this reason, we have used PG as a typical anionic
phospholipid in later experiments probing the lytic
mechanism for squalamine.
3.3. The binding of squalamine to zwitterionic lipid
˝esicles
The ability of squalamine to induce CF leakage
from LUVs composed of PC, a zwitterionic phospho-
lipid, was also measured. As shown in Fig. 5,
squalamine does cause the leakage of CF from PC
LUVs at low lipid concentrations. This leakage can
be used to calculate an apparent binding constant of
4 y1  .6.5=10 M Table 1 . However, at higher lipid
concentrations, and unlike the behavior observed be-
tween squalamine and anionic phospholipids, the
leakage behavior changes. Specifically, the relation-
ship between the leakage and the logarithm of the
w x w xsqualamine r phospholipid ratio is no longer sig-
moidal, and is better described as linear. Also, some
of the carboxyfluorescein becomes inaccessible to
squalamine leakage; the maximum leakage decreases
with increasing lipid concentration see inset to Fig.
.5 . Since the leakage behavior changes with PC
concentration, no ED value could be estimated for50
this lipid at high lipid concentrations.
3.4. Mode of carboxyfluorescein leakage induced by
squalamine
Carboxyfluorescein may be released from LUVs
through one of two different mechanisms. Either all
of the dye is released from a population of vesicles,
Fig. 5. Dose–response curves describing the leakage rate of CF
from PC LUVs as a function of the logarithm of the
squalaminerlipid molar ratio. At high lipid concentrations, the
dose–response relationship differs from that measured at low
lipid concentrations. The errors in the leakage rate and the
w x w xsqualamine r phospholipid molar ratios are estimated to be
"5%. Inset: The maximum observed leakage rate for PC vesicles
decreases with the PC concentration in the fluorescence cuvette.
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leaving a second population of intact vesicles con-
taining all of the CF initially encapsulated ‘all-or-
.none’ leakage , or some portion of CF is released
 .from all of the vesicles ‘graded’ leakage . Tradition-
ally, all-or-none leakage is distinguished from graded
leakage by adding a pore-forming agent to vesicles
containing CF, separating released CF from the vesi-
cles using a size exclusion column, and measuring
the fluorescence quenching in the vesicles. Compari-
son of the percent quenching before and after adding
the permeabilizing agent determines the mode of
leakage. If the internal quenching does not change,
then the leakage is ‘all-or-none’. If the internal
quenching varies as a function of added agent, then
the leakage is ‘graded’.
Recently, a method was described which allows
for the direct measurement of the leakage mechanism
w x9,16 . To distinguish between the two mechanisms,
LUVs were loaded with the fluorescent dye ANTS
and the quenching agent DPX. The amount of fluo-
rescence quenching for the dye ANTS after the addi-
tion of squalamine to the vesicles can be used to
determine whether the leakage is all-or-none or graded
 .see rationale described in Section 2.4 . The direct
Fig. 6. The results of the all-or-none experiment using squalamine
and PG LUVs. The increase in Q as a function of f indicatesin out
a graded leakage mechanism.
Fig. 7. The results of the all-or-none experiment using squalamine
and PC LUVs. The results at low PC concentrations indicate a
graded leakage mechanism. Above approximately 10 mM lipid,
the experimental data deviates from expected, in parallel to the
leakage results shown in Fig. 5. Open circles: 0.6–6 mM PC;
Closed circles: 15–40 mM PC.
method has several advantages over separation with a
size exclusion column. In the direct method, a series
of internal quenching measurements can be made on
the same vesicle sample, while in the column method,
only a single quenching measurement can be made
on each sample. The direct method also requires less
lytic agent, important since only small quantities of
squalamine were available.
As shown in Fig. 6, the leakage of the fluorescent
dye ANTS induced by squalamine from anionic lipid
vesicles is proportional to the fraction of ANTS re-
leased by squalamine. Hence, squalamine appears to
operate via a graded mechanism. This suggests that a
transient pore is formed by squalamine when interact-
ing with phospholipid vesicles. The same experiment
was repeated using squalamine and the zwitterionic
 .lipid PC Fig. 7 . At low lipid concentrations, the
experimental results indicate that the leakage of ANTS
from PC vesicles also proceeds by a graded mecha-
nism. At high PC concentrations, the experimentally
determined data pairs Q and f no longer fall onins out
the same smooth curve, but lie on approximately the
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 .same value of f see Fig. 7 . This anomalous resultout
mirrors the leakage data obtained with high PC con-
centrations.
3.5. The size of the membrane pore
If squalamine forms a discrete membrane pore of
defined size, then smaller molecules should pass
through the pore more easily than large molecules.
We have examined the leakage of the small fluores-
cent dyes CF, calcein, and ANTS. All are approxi-
mately equal in molecular weight, and all leak from
vesicles at the same rate at a given squalaminerlipid
 .ratio data not shown . To estimate the size of the
pore generated by squalamine, vesicles were prepared
encapsulating three different labeled dextrans: fluo-
rescein-labeled dextran with a molecular weight of
 .70,000 grmol FD-70 , tetramethylrhodamine-labeled
dextran with a molecular weight of 10,000 grmol
 .TMR-10 , and fluorescein-labeled dextran with a
 .molecular weight of 4,000 FD-4 . These dyes are
Fig. 8. The separation of fluorescently labeled dextrans and
LUVs with encapsulated fluorophores by Sephacryl S-400-HR
column chromatography. The column elution buffer was 10 mM
HEPES, 50 mM KCl, 1 mM EDTA, 3 mM sodium azide, pH 7.0,
 .at room temperature 20–228C , with a flow rate of 1.2 ml per
minute. The ordinant axis represents column fraction number
 .0.75 ml fractions , while the abscissa is relative fluorescence
 .l s491 nm; l s516 nm in counts per second.ex em
Fig. 9. Total phosphate analysis of fractions from the Sephacryl
S-400-HR column. Elution conditions were identical to those
given in Fig. 8. Closed circles: PG LUVs applied to the column
in the absence of squalamine; closed squares: squalamine-treated
 .PG LUVs at a squalaminerphospholipid ratio of 0.058r1 .
separable from each other, and from LUVs, using
Sephacryl S-400-HR size exclusion chromatography
 .Fig. 8 . Curiously, the 10 K dextran labeled with
tetramethylrhodamine elutes from the column after
the fluorescein-labeled 4 K dextran; we attribute this
discrepancy to interactions between the tetramethyl-
rhodamine and the column media. In a control study,
a tetrakisporphrin-labeled 10 K dextran elutes be-
tween the 70 K and 4 K fluorescein-labeled dextrans,
 .as expected data not shown . Since the spurious
elution behavior results in better separation of the
dextrans, the tetramethylrhodamine-labeled material
was used.
PG vesicles containing three fluorescent dextrans
were subjected to size exclusion chromatography Fig.
.9 . Analysis of phosphate content shows that the
LUVs elute as a single peak. When PG vesicles are
treated with squalamine, however, the elution profile
 .changes. The elution time ˝ remains the same fore
the largest LUVs, but the phosphate concentration is
decreased in the peak. Phosphate is also detected in
later fractions. The change in ˝ suggests size hetero-e
geneity due to the formation of smaller vesicles.
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Fig. 10. Fluorescence analysis of fractions collected from the
Sephacryl S-400-HR column. Elution conditions were identical to
 .those given in Fig. 8. A PG LUVs treated with distilled water.
 .B Squalamine-treated PG LUVs, where the molar ratio of
 .squalaminerPG is 0.058r1. C The contents of the LUVs found
in fractions 13–19 from the bottom trace, released from the
vesicles as described in Section 2. The three traces were manu-
ally offset from one another; the background fluorescence in all
cases is less than 10,000 cps.
Fig. 10 describes the effect of squalamine on the
release of fluorescent dextrans from PG LUVs. When
PG LUVs containing three fluorescent dextrans are
treated with distilled water, no leakage of the fluores-
 .cent dextrans is observed Fig. 10A . Squalamine,
when added to vesicles at a squalaminerphospholipid
ratio of 0.058r1, induces the release of FD-4 from
 .PG LUVs Fig. 10B . Some of the FD-70 appears to
be released as well, but the amount is difficult to
quantitate, since some smaller vesicles generated by
squalamine elute in the same column fractions see
.Fig. 9 . The increased fluorescence in these fractions
may be due to fluorescent dextrans within the smaller
vesicles.
To confirm the leakage of FD-4 from the vesicles
and the retention of the larger dextrans, after treat-
ment with squalamine and separation on the Sephacryl
S-400-HR column, the larger vesicles column frac-
.tions 13–19; see Fig. 9 were harvested, concentrated
by lyophilization, suspended in buffer containing
0.1% Triton X-100, and rechromatographed. After
squalamine treatment, only the FD-70 and TMR-10
remain within the vesicles; all of the FD-4 has leaked
 .out Fig. 10C . This indicates that the size of the pore
created by squalamine is large enough to allow a
 .  .Fig. 11. Negative-stain electron micrographs of PGrPC 3r7 wrw LUVs. A PGrPC vesicles prepared in the absence of squalamine.
 .B PGrPC vesicles prepared after treatment with squalamine at a squalaminerphospholipid molar ratio of 0.047r1. Both micrographs
are magnified 20,000 times, and the bar on the micrograph corresponds to 1 mM.
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molecule with a molecular weight of 4000 grmol to
leak out, but not sufficiently large to allow a molecule
with molecular weight of 10,000 grmol to leak.
Since the hydrodynamic radius of FD-4 is reported to
w xbe 1.85 nm 9 and that of a 10 K molecular weight
w xdextran is 2.2 nm 20 , this suggests that the size of
the membrane defect caused by squalamine is be-
tween 1.8–2.2 nm.
3.6. Electron microscopy
Since squalamine induces the leakage of fluores-
cent dyes encapsulated within LUVs, we were curi-
ous to see if gross morphological changes in the
vesicles accompanied the leakage event. Vesicles
were prepared using PC or a mixture of PCrPG
 .70r30 wrw , and the effect of squalamine on these
vesicles observed by negative stain electron mi-
croscopy. Pure PG vesicles were also prepared but
not analyzed due to poor staining. In the absence of
squalamine, unilamellar vesicles were observed in all
Fig. 12. The mean vesicular diameter decreases in the presence of
squalamine. Squalamine was added to either PC LUVs or PCrPG
 .7r3 wrw LUVs in the ratios shown in the Figure. Negative
stain electron micrographs were taken and analyzed for vesicle
size. Between 50–100 vesicles per micrograph were analyzed,
and the points represent the mean diameter with the error bars
representing one standard deviation. Points marked with an aster-
isk are different from the zero squalamine controls at the 99%
confidence level.
cases with diameters of approximately 95 nm Fig.
.11A , consistent with LUVs previously prepared by
w xextrusion 12 . Upon the addition of squalamine to
the vesicles at squalaminerphospholipid ratios rele-
vant to contents leakage, some changes in the appear-
ance of the vesicles are observed. In particular, darkly
stained patches appear on the surface of many of the
 .vesicles in the presence of squalamine Fig. 11B .
The patches appear on both PC and PCrPG vesicles.
The sizes of the vesicles were measured before and
after squalamine treatment. As seen in Fig. 12, the
vesicular diameters decreased as a function of the
squalamine to phospholipid molar ratio. This result
corroborates our interpretation of the size exclusion
chromatography study, i.e., that squalamine results in
the formation of smaller vesicles. Vesicles prepared
from PC were less sensitive to squalamine than vesi-
cles prepared from either PG or PGrPC mixtures.
3.7. Critical micelle concentration measurements
Squalamine has some structural similarity to a bile
acid; this prompted us to hypothesize that squalamine
might work through a detergent-like disruption of a
lamellar membrane. An attempt was made to study
the cmc of squalamine by measuring the partitioning
of spectroscopic probes that are known to incorporate
into the hydrophobic environment of detergent mi-
celles. Two different probes were used: 1-phenyl-N-
naphthylamine, which is fluorescent in a hydrophobic
w xenvironment 18 , and Orange-OT, which is insoluble
in aqueous solutions but has a high extinction coeffi-
cient at 492 nm when solubilized in a hydrophobic
w xenvironment 19 . Neither of the two dyes partitioned
into a hydrophobic environment in squalamine solu-
tions ranging in concentration between 3 mM and 2.3
mM. Both dyes did partition into a hydrophobic
environment in the presence of the bile acid deoxy-
cholate, allowing us to determine a cmc of 7.1 mM
 .data not shown , comparable to literature values
w x21 . Since this validates the method, we therefore
conclude that squalamine must not form sufficiently
large aggregates to define a distinct hydrophobic
environment in the concentration range tested.
We were also concerned that squalamine micelles
might form in a concentrated stock solution, and that
upon dilution into a solution containing lipid vesicles
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these micelles would rapidly generate holes in mem-
branes before the micelles could dissociate into
monomeric squalamine. The interaction of squalamine
micelles with membranes, followed by dissolution
into aminosterol monomers, could explain the bipha-
sic nature of the leakage behavior. To insure that
squalamine micelles were not causing leakage,
 .squalamine was added from 1.0 mgrml 1.08 mM ,
0.1 mgrml, and 0.01 mgrml stock solutions into
cuvettes containing PG vesicles with encapsulated
CF. The leakage rates measured after adding
squalamine to the same final concentration agreed
within 5%, regardless of the concentration of the
squalamine stock solution. As one final test,
squalamine was added to buffer in the fluorescence
cuvette to the same final concentration as above 3
.mM , incubated at 308C for 5 min, and then PG
vesicles containing CF were added to the cuvette.
The leakage rate measured using this experimental
protocol was identical to that measured by adding
squalamine to a cuvette already containing PG vesi-
cles. These various studies suggest that CF leakage
from vesicles does not result from the interaction of
squalamine micelles with vesicle membranes.
Fig. 13. Phospholipid solubilized by squalamine from PC or PG
MLVs. Phospholipid in buffer was treated with squalamine in the
ratios shown in the Figure, and then centrifuged. Intact MLVs
sedimented to the bottom of the centrifuge tube, while solubilized
phospholipid remained in the supernatant and was measured by
total phosphate assay. Circles: PC MLVs; Squares: PG MLVs.
3.8. Phospholipid solubilization
As a final indication of possible micelle formation,
the ability of squalamine to solubilize phospholipid
 .from multilamellar vesicles MLVs was measured.
 .Phospholipid 0.18 mM is mixed with squalamine
 .0–0.44 mM in a polycarbonate centrifuge tube,
incubated for 10 min, and centrifuged. The super-
natant is then assayed for phospholipid. As shown in
Fig. 13, squalamine can solubilize both PC and PG
MLVs at very high squalaminerphospholipid ratios.
Here, PC is solubilized at lower squalamine concen-
trations than PG, in contrast to the leakage and
electron microscopy results where LUVs containing
PG are more sensitive to squalamine than PC vesi-
cles.
4. Discussion
4.1. The lipid selecti˝ity of squalamine
In this report, squalamine is shown to effect the
leakage of small fluorescent molecules from LUVs
prepared from both anionic and zwitterionic LUVs.
Squalamine exhibits a distinct preference for anionic
lipid. As seen in Table 1, squalamine causes the
leakage of CF equally well from PG and PS LUVs,
but less efficiently from CL LUVs. The binding
constants reported in Table 1, however, were deter-
mined relative to total phospholipid concentration. If
instead the binding constants were calculated relative
to total lipid phosphate, the binding of squalamine to
CL LUVs would approach the levels observed for PG
and PS. The minimal selection between anionic phos-
pholipids and the clearly weaker binding to PC LUVs
suggests that an electrostatic interaction between the
squalamine polyamine and lipid phosphate is a pri-
mary determinant of membrane binding.
The kinetics of CF leakage indicate a rapid initial
phase, followed by a rapid decrease in dye leakage
until no additional material leaks from the vesicles
 .Fig. 2 . These biphasic leakage kinetics might be
explained by an ‘all-or-none’ mechanism. Upon addi-
tion of squalamine, some of the vesicles totally empty
their contents, while a second population is unaf-
fected and retain all of their encapsulated dye. Fur-
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ther experimental analysis of the leakage mechanism
 .Figs. 6 and 7 indicates that the leakage of fluores-
cent dyes induced by squalamine is graded in nature.
The leakage mechanism was determined using only
PG and PC vesicles, with the assumption that
squalamine will interact with LUVs prepared from
any anionic lipid in like manner. The graded leakage
mechanism observed for both anionic and zwitteri-
onic phospholipid must be accounted for in any
mechanism explaining the action of squalamine on
membranes.
The kinetic behavior of squalamine-induced CF
leakage is reminiscent of that observed for the an-
timicrobial peptide magainin-2-amide. Upon addition
to LUVs, magainin collects on the surface of lipid
vesicles, aggregates, and inserts into the bilayer as a
multimeric pore. The peptides comprising the tran-
sient pore relax and redistribute on both leaflets of
the vesicle bilayer. After relaxation, the peptide con-
centrations on both sides of the bilayer are insuffi-
cient to generate new pores, and the dye leakage
w xceases 22 . While it is unlikely that squalamine
interacts with LUVs in exactly the same manner as
magainin, a general mechanism describing
squalamine-induced dye leakage may consist of three
 .similar steps: 1 membrane binding and aggregation,
 .  .2 pore formation, and 3 pore relaxation and dilu-
tion.
4.2. Squalamine decreases the size of LUVs
One of the unexpected observations with
squalamine is that at squalaminerphospholipid ratios
sufficient to cause CF leakage, squalamine creates
size heterogeneity in vesicles. The average vesicular
size decreases from about 95 nm in the absence of
squalamine to less than 70 nm when the
squalaminerphospholipid ratio exceeds 1r20 Fig.
.12 . The decrease in vesicular size is observed both
by electron microscopy and size exclusion chro-
 .matography Fig. 9 .
4.3. Is squalamine a detergent?
One interpretation for the mechanism of vesicular
and cell lysis caused by squalamine is a detergent-like
disruption of the phospholipid bilayer. Detergents
have been proposed to disrupt phospholipid lipo-
w xsomes via a three-stage mechanism 23 . In stage I,
detergent monomers are incorporated into phospho-
lipid bilayers until the liposome is saturated, at which
point mixed phospholipid–detergent micelles form
and stage II begins. By stage III, the lamellar to
micellar transition is complete, with no remaining
liposomes and all of the phospholipids are found in
mixed micelles. The three-stage mechanism has been
used to understand the action of many detergents,
including Triton X-100, octyl glucoside, and sodium
w xcholate 24–29 .
In some ways, the ability of squalamine to form
holes in membranes resembles the interaction of sim-
ple detergents with lipid membranes. Entrapped CF is
released from anionic lipid vesicles when added
squalamine exceeds a critical squalaminerphos-
pholipid molar ratio. The same behavior is observed
in the interaction between egg yolk lecithin and either
w xthe bile salt surfactant sodium cholate 26 or the
w xnonionic surfactant Triton X-100 29,30 . Also, when
squalamine is added to LUVs, the vesicular size
decreases as a function of the squalaminerphos-
 .pholipid molar ratio Fig. 12 . In the interaction
between PC and sodium cholate, the formation of
small vesicles is used to explain the appearance of an
31 w xisotropic P NMR resonance 26 . At high
squalaminerphospholipid molar ratios, squalamine
can solubilize both PG and PC from MLVs, behavior
typical of a surfactant.
In other ways, squalamine does not exhibit deter-
gent-like behavior. Squalamine is a hydrophobic
steroid with polar substituents at positions 3, 7, and
24 on the steroid backbone. As a result, the separa-
tion of hydrophobic and hydrophillic regions in
squalamine is difficult to define. Since no critical
micelle concentration can be measured by methods
used here, squalamine seems incapable of forming
micelles in the absence of phospholipid. Squalamine
does solubilize phospholipid, but only at very high
squalaminerphospholipid ratios, much higher than
required for dye leakage or reduction of average
vesicular size.
The lipid selectivity of squalamine is also striking.
The ability of squalamine to induce the leakage of
dye encapsulated within PC LUVs is much different
from that for LUVs prepared from anionic lipid. At
higher PC concentrations, a population of CF resists
leakage; this amount increases as a function of phos-
( )B.S. Selinsky et al.rBiochimica et Biophysica Acta 1370 1998 218–234232
pholipid concentration. There is lipid selectivity in
the squalamine-induced formation of small vesicles
where PG vesicles demonstrate size heterogeneity at
lower squalaminerphospholipid ratios than for PC
.vesicles , and in squalamine-induced lipid solubiliza-
tion where PC is solubilized at lower squalamine
.concentrations than PG . To the best of our knowl-
edge, only one study has previously examined the
interaction of different lipids with a detergent Triton
. w xX-100 31 . While some solubility differences were
noted, none were related to lipid charge.
4.4. Membrane disruption and antimicrobial acti˝ity
Squalamine is a potent antimicrobial agent, with
 .minimum inhibitory concentrations MICs of less
w xthan 10 mM against most microorganisms 4 . In the
experiments reported here, squalamine is studied at
similar concentrations, but the LUVs suspensions are
much more dilute than the cellular suspensions used
in determining MICs. As a result, the lytic behavior
observed with squalamine and LUVs may not relate
to the antimicrobial activity of squalamine. Since
squalamine does preferentially interact with anionic
lipid, the selectivity of squalamine for prokaryotic
over eukaryotic cells and the low hemolytic activity
of squalamine indicates that squalamine selects for
cellular surfaces based upon electrostatic interactions.
Future studies in this laboratory will examine the
interactions of squalamine to bacterial membranes, to
see if squalamine can lyse bacterial membranes, and
if so, to determine the concentration dependence of
the lytic activity.
4.5. A model for squalamine-induced bilayer disrup-
tion
We hypothesize that squalamine first binds to the
surface of phospholipid vesicles, where binding affin-
ity is related to vesicle charge and the surface organi-
zation of the lipid. Binding is initially electrostatic in
nature, and absolutely requires the presence of phos-
pholipid. Squalamine is soluble in distilled water to
 .concentrations of 20 mgrml 21 mM , but is insolu-
ble in 10 mM phosphate buffer. The solubility behav-
ior suggests a strong, specific interaction between
squalamine and phosphate, presumedly at the proto-
nated polyamine nitrogens. In studies of other sterols
the polar moieties have been shown to reside at the
bilayer surface. For example, cholesterol 3-sulfate
orients in zwitterionic membranes with the sulfate
group at the bilayer surface. Cholesterol sulfate is a
bilayer stabilizing agent, but in the presence of cal-
cium ions destabilizes phosphatidylethanolamine bi-
w xlayers 32 . Also, studies using a spin-labeled sterol,
with a nitroxide added to the side chain in the
approximate position of the squalamine sulfate group,
suggest that the nitroxide is located at the surface of
the membrane in close proximity with the choline
w xN-methyl groups 33 . These studies suggest that
negatively charged substituents attached to sterols
prefer to sit at the surface of a bilayer, but might
change their orientation and destabilize bilayers un-
der appropriate conditions. Future squalamine studies
in our laboratory will examine in more detail the
effects of pH and phospholipid structure upon mem-
brane binding and stability.
After binding, squalamine aggregates on the vesi-
cle surface. The molecular nature of the aggregate is
unknown at present, but is suggested in negative stain
electron micrographs of squalamine-treated vesicles.
Darkly staining patches are apparent, which might
result from binding of the negatively charged molyb-
date stain to squalamine amine groups not tied to
phospholipid phosphate, or from invaginations where
the negative stain could accumulate. The aggregates
create a defect in the membrane, allowing the release
of vesicular contents with molecular weight of less
than 10,000 grmol. The antimicrobial peptide de-
fensin generates a pore of similar size in its interac-
w xtion with phospholipid membranes 17 .
While the structure of the squalamine aggregate is
unknown, we would suggest that the aggregate con-
tains both squalamine and phospholipid. The antimi-
crobial peptide magainin has been demonstrated to
w xinclude bound phospholipid in its pore structure 34 .
The formation of small vesicles, and the ultimate
solubilization of phospholipid by squalamine sup-
ports a association between aminosterol and phospho-
lipid. Also, the aggregate is not stable in the mem-
brane, and will relax to a different structure. How-
ever, the relaxation mechanism is somewhat different
when squalamine is complexed to anionic lipid than
when complexed to zwitterionic lipid. Squalamine,
complexed with either anionic or zwitterionic lipid,
will extract itself from LUVs in the form of small
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vesicles. Vesicles containing squalamine and anionic
lipid exist as such until sufficient squalamine is added
to completely saturate all vesicles, at which time
solubilization into squalaminerphospholipid mixed
micelles occurs. Vesicles containing squalamine and
zwitterionic lipid can act as a squalamine ‘sponge’,
interacting with free squalamine and other
squalaminerPC complexes, protecting PC vesicles
with less bound squalamine and allowing them to
retain more encapsulated dye.
In a recent report, an analog of squalamine was
shown to act as an anion ionophore in PG membranes
w x35 . A model for an anion pore was proposed, where
the positively charged amine groups in the analog
line the channel and the more polar sterol interfaces
with the lipid acyl chains. There is no evidence in our
experiments which supports a model of this type. In
particular, the size of the pore generated in the
squalamine-induced lysis of membranes must be large
enough to allow the passage of fluorescent dyes. For
this squalamine analog, the membrane permeability
was limited to small ions. In fact, the observation of
ion transport using the squalamine analog depended
upon the continued encapsulation of a pH-sensitive
fluorescent dye within phospholipid vesicles. Al-
though this analog possesses some of the structural
elements of squalamine, the orientation of these ele-
ments and the structure of the sterol ring are much
different. Finally, we have tested squalamine in both
anionic and zwitterionic LUVs, and have found no
evidence for ionophoric activity using the methodolo-
gies described in the unpublished report. 1 The an-
timicrobial mechanism for squalamine may be differ-
ent from the antimicrobial mechanism for the
squalamine analog.
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